Data / Form D filings / NKA Bio, Inc.
NKA Bio, Inc.: Form D filing
NKA Bio, Inc., a health care company in Baltimore, MD, filed a Form D with the SEC in 2023. The latest, on April 3, 2023, reports $30,000 sold of a $2 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2401 WEST BELVEDERE AVENUE, BIOINCUBATOR - LAB 317, Baltimore, MD, 21215
- Phone
- (443) 465-7702
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1967539
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | New notice | $2,000,000 | $30,000 | $1,970,000 | 3 | Mar 21, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lewis C. Hibbs | Executive Officer, Director | |
| Les E. Johnson | Executive Officer, Director | |
| Susan G. Hibbs | Executive Officer, Director |
Other health care companies in Maryland that filed recently
- ColoWatch, Inc. /MD/ $1.3 million · Oct 19, 2026
- Aromha, Inc. $75,000 · Sep 24, 2026
- Functional Longevity Labs, Inc. $25,000 · Sep 21, 2026
- Terrace Systems, Inc. $250,000 · Sep 16, 2026
- Savannah Therapeutics, Inc $3.9 million · Sep 11, 2026
- Featherglass Health, Inc. $25,000 · Sep 4, 2026
Every Form D from the week of Apr 3, 2023 · All recent filings in Maryland · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what NKA Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.